| Controller to total medications < 50% | Inappropriate SABA use | |||||
---|---|---|---|---|---|---|---|
Group | Variable | Odds Ratio | 95% CI | P value | Odds Ratio | 95% CI | P value |
(Lower, Upper) | (Lower, Upper) | ||||||
Socio-demographic | Sex (female = 1) | 0.97 | 0.95–0.99 | <.0003 | 0.78 | 0.76–0.81 | <.0003 |
Higher SES | 0.97 | 0.97–0.98 | <.0001 | 0.98 | 0.97–0.98 | <.0001 | |
Year | 0.99 | 0.98–1.00 | <.0001 | 0.96 | 0.96–0.97 | <.0001 | |
Age | 0.81 | 0.81–0.82 | <.0001 | 0.9 | 0.89–0.91 | <.0001 | |
Asthma treatment variables | Asthma-related hospitalization | 1.63 | 1.51–1.76 | <.0001 | 0.99 | 0.83–01.18 | 0.9222 |
Asthma-related outpatient visit | 0.95 | 0.94–0.96 | <.0001 | 0.89 | 0.88–0.91 | <.0001 | |
Oral corticosteroid | 1.28 | 1.25–1.30 | <.0001 | 0.4 | 0.38–0.41 | <.0001 | |
Severity of Asthma | 1.18 | 1.16–1.20 | <.0001 | 3.6 | 3.52–3.69 | <.0001 | |
Comorbidity-related variables | Modified Charlson score | 1.11 | 1.09–1.12 | <.0001 | 0.98 | 0.96–1.00 | 0.1033 |
None asthma related hospitalization | 1.01 | 1.00–1.02 | 0.0009 | 1.01 | 1.00–1.03 | 0.0789 | |
None asthma related outpatient visit | 1.00 | 1.00–1.00 | <.0001 | 1.00 | 1.00–1.00 | 0.0137 | |
Type & quality of care | Having received pulmonary function test | 0.95 | 0.92–0.97 | <.0003 | 0.87 | 0.82–0.92 | <.0001 |
Respirologist consultation | 0.57 | 0.54–0.59 | <.0001 | 0.54 | 049–0.60 | <.0001 | |
Internal medicine consultation | 0.98 | 0.93–1.03 | 0.5501 | 0.74 | 0.67–0.81 | 0.0014 | |
General Practitioner Asthma visit | 0.67 | 0.66–0.68 | <.0001 | 1.16 | 1.12–1.19 | <.0001 | |
Continuity of care (COC) | Â | Â | Â | Â | Â | Â | |
COC = 0 | – | – | – |  | – | – | |
COC > 0 and COC < 50% | 0.84 | 0.82–0.86 | <.0001 | 0.76 | 0.74–0.79 | <.0001 | |
COC > =50% and OC < 100% | 0.86 | 0.84–0.88 | <.0001 | 0.84 | 0.80–0.88 | 0.0014 | |
COC = 100% | 0.86 | 0.83–0.83 | <.0001 | 0.85 | 0.80–0.90 | <.0001 |